Pathologic features the urologist should expect on a prostate biopsy

被引:10
作者
Che, MX
Sakr, W
Grignon, D
机构
[1] Harper Univ Hosp, Dept Pathol, Detroit, MI 48201 USA
[2] Karmanos Canc Inst, Detroit, MI 48201 USA
[3] Wayne State Univ, Detroit, MI 48201 USA
关键词
prostate biopsy; minimal cancer; high-grade prostatic intraepithelial neoplasia; atypical small acinar proliferation; repeat biopsy;
D O I
10.1016/S1078-1439(03)00008-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In recent years, the pathological evaluation of prostate biopsy specimens has made great improvements in diagnostic accuracy and comprehensiveness. In this article, we review major pathological findings on prostate biopsy, their interpretation and reporting, as well as their clinical significance and utility. We discuss especially the clinically relevant histological features in either a positive or negative biopsy. We emphasize that both Gleason score and extent of cancer involvement in a needle core biopsy are important predictors of clinical outcome after either radical prostatectomy or radiation. Special issues regarding diagnosis and grading of minimal cancer on needle core biopsies are discussed. We also highlight the current standards on high-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on needle core biopsies. In summary, the pathology reports on needle biopsies are far beyond the simple presence or absence of cancer; they contain invaluable information to clinicians on patient management and counseling. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:153 / 161
页数:9
相关论文
共 84 条
[11]  
Cheville JC, 1997, AM J CLIN PATHOL, V108, P633
[12]   RESULTS OF CONSERVATIVE MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER [J].
CHODAK, GW ;
THISTED, RA ;
GERBER, GS ;
JOHANSSON, JE ;
ADOLFSSON, J ;
JONES, GW ;
CHISHOLM, GD ;
MOSKOVITZ, B ;
LIVNE, PM ;
WARNER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (04) :242-248
[13]   Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma [J].
Conrad, S ;
Graefen, M ;
Pichlmeier, U ;
Henke, RP ;
Erbersdobler, A ;
Hammerer, PG ;
Huland, H .
JOURNAL OF UROLOGY, 2002, 167 (02) :521-525
[14]   Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Schultz, D ;
Fondurulia, J ;
Chen, MH ;
Tomaszewski, JE ;
Renshaw, AA ;
Wein, A ;
Richie, JP .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) :1164-1172
[15]   Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop? [J].
Djavan, B ;
Ravery, V ;
Zlotta, A ;
Dobronski, P ;
Dobrovits, M ;
Fakhari, M ;
Seitz, C ;
Susani, M ;
Borkowski, A ;
Boccon-Gibod, L ;
Schulman, CC ;
Marberger, M .
JOURNAL OF UROLOGY, 2001, 166 (05) :1679-1683
[16]  
EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO
[17]  
2-Y
[18]   Disease progression following radical prostatectomy in men with Gleason score 7 tumor [J].
Epstein, JI ;
Pound, CR ;
Partin, AW ;
Walsh, PC .
JOURNAL OF UROLOGY, 1998, 160 (01) :97-100
[19]   Biopsy Gleason score: How does it correlate with the final pathological diagnosis in prostate cancer? [J].
Fernandes, ET ;
Sundaram, CP ;
Long, R ;
Soltani, M ;
Ercole, CJ .
BRITISH JOURNAL OF UROLOGY, 1997, 79 (04) :615-617
[20]   Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy [J].
Freedland, SJ ;
Csathy, GS ;
Dorey, F ;
Aronson, WJ .
UROLOGY, 2002, 60 (01) :84-88